UBS raised the target price for RemeGen (09995) to HKD22.6 from HKD20.2 and maintained the "buy" rating.
The research house said based on Q324 results and regulatory progress, it revises up 2025/26 revenue forecasts by 1.9%/1.6%, and revises down R&D/selling expense ratio by 1/1ppt and 10/5ppt, respectively.
31/10/2024 15:41
{I-bank focus}UBS raises RemeGen (09995) to HKD22.6
Next︰31/10/2024 15:12 {I-bank focus}Morgan raises China Res Beer (00291) to HKD34
31/10/2024 14:39 {I-bank focus}HSBC raises Tsingtao Brewery to HKD59.2
30/10/2024 16:08 {I-bank focus}Macquarie raises Haier Smart Home to HKD40.5
30/10/2024 15:03 {I-bank focus}Macquarie lowers Tsingtao Brewery to HKD60
30/10/2024 14:35 {I-bank focus}BOCI raises WuXi AppTec (02359) to HKD62
29/10/2024 15:36 {I-bank focus}HSBC lowers CNOOC (00883) to HKD21.5
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
